IRulya Therapeutics Inc. (IRLA) stock
Price, quality score, analyst targets, a 30-day Kronos AI forecast and a Shariah screen for IRulya Therapeutics Inc., updated every trading day.
Health Care · Biotechnology: Biological Products (No Diagnostic Substances)
IRulya Therapeutics Inc. (IRLA) is a Health Care company in Biotechnology: Biological Products (No Diagnostic Substances), worth $352M. It trades at $32.95, up 1.48% today. 8 analysts' average target of $75.63 implies +129.5% from today's price. Kronos AI's 30-day forecast is −17.6% (0 of 8 simulated paths end higher).
Open the full interactive analysis →Charts, technical signals, DCF fair value and ownership
Analyst price targets
| Average target | $75.63 |
| Low – high | $68.00 – $98.00 |
| Analysts | 8 |
| Upside to average | +129.5% |
Kronos AI 30-day forecast
| Expected close | $26.75 (−17.6%) |
| Likely range | −23.4% … −7.5% |
| As of | 2026-10-27 |
Quality scores
Not scored: the financial data for this listing is incomplete.
Shariah screen
| Business activity | Passes |
| Debt and cash (AAOIFI 30%) | Not checked for this listing |
Halal Health Care stocks · Zakat calculator · Purification calculator